By the end of next year, Harpoon Medical's minimally invasive surgical tool could be in operating rooms across Europe.
Harpoon still is testing the technology, but believes its device could revolutionize mitral valve repair, a hours-long surgery that requires splitting the breastbone and stopping the heart. Harpoon's tool can finish the job in a hour and a half through a small incision.
The Baltimore startup, whose device was just a prototype in a surgeon's office three years ago, has raised $17.5 million and has a financing deal with Edwards Lifesciences that could result in the California device-maker acquiring Harpoon next year.
Harpoon's success is thanks, in part,...